Implantable electroacupuncture system and method
A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a patient. The duty cycle is a ratio of T 3 to T 4 . Each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
1. A method, comprising:
generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05, wherein
the duty cycle is a ratio of T 3 to T 4 ,
each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes, and
the implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms; and
applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a patient.
2. The method of claim 1 , wherein:
a housing of the implantable stimulator is coin-sized and coin-shaped; and
the primary battery located within the implantable stimulator is a coin-cell battery.
3. The method of claim 1 , wherein the applying of the stimulation sessions to the patient comprises applying the stimulation sessions to a location within the patient that comprises at least one of acupoints ST36, SP4, ST37, ST40, SP6, SP9, K16, and LR8.
4. The method of claim 1 , wherein T 3 is at least 10 minutes and less than 60 minutes, and wherein T 4 is at least 1440 minutes.
5. The method of claim 1 , wherein the primary battery located within the implantable stimulator has a capacity of less than 60 milliamp-hours (mAh).
6. The method of claim 1 , wherein the applying of the stimulation sessions to the patient is configured to treat at least one of obesity, dyslipidemia, and a genitourinary disease of the patient.
7. The method of claim 6 , wherein the applying of the stimulation sessions is configured to treat the genitourinary disease, and wherein the applying of the stimulation session comprises applying the stimulation sessions to a tibial nerve of the patient.
8. An implantable stimulator, comprising:
a housing;
pulse generation circuitry located within the housing, the pulse generation circuitry configured to
generate stimulation sessions at a duty cycle that is less than 0.05, and
apply, in accordance with the duty cycle, the stimulation sessions to a patient by way of an electrode array communicatively coupled to the pulse generation circuitry; and
a primary battery located within the housing and having an internal impedance greater than 5 ohms, the primary battery configured to provide operating power to the pulse generation circuitry;
wherein
the duty cycle is a ratio of T 3 to T 4 , and
each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes.
9. The implantable stimulator of claim 8 , wherein:
the housing of the implantable stimulator is coin-sized and coin-shaped; and
the primary battery located within the housing is a coin-cell battery.
10. The implantable stimulator of claim 8 , wherein the primary battery located within the housing has a capacity of less than 60 milliamp-hours (mAh).
11. The implantable stimulator of claim 8 , wherein:
the electrode array comprises a central electrode of a first polarity centrally located on a first surface of a housing of the implantable stimulator and an annular electrode of a second polarity and that is spaced apart from the central electrode; and
the pulse generation circuitry is configured to apply the stimulation sessions to the patient by way of the electrode array by applying the stimulation sessions to the patient by way of the central electrode and the annular electrode.
12. The implantable stimulator of claim 11 , wherein the annular electrode is located on the first surface of the housing.
13. The implantable stimulator of claim 11 , wherein the annular electrode comprises a ring electrode located around a perimeter edge of the housing.
14. The implantable stimulator of claim 8 , wherein:
the electrode array comprises a plurality of electrodes located on a lead that is attached to the implantable stimulator; and
the pulse generation circuitry is configured to apply the stimulation sessions to the location by way of the electrode array by applying the stimulation sessions to the location by way of the plurality of electrodes located on the lead.
15. The implantable stimulator of claim 8 , wherein the applying of the stimulation sessions to the patient is configured to treat at least one of obesity, dyslipidemia, and a genitourinary disease of the patient.
16. An implantable stimulator, comprising:
a housing;
pulse generation circuitry located within the housing, the pulse generation circuitry configured to
generate stimulation sessions at a duty cycle that is less than 0.05, and
apply, in accordance with the duty cycle, the stimulation sessions to a patient by way of an electrode array communicatively coupled to the pulse generation circuitry; and
a primary battery located within the housing and that is a coin-cell battery, the primary battery configured to provide operating power to the pulse generation circuitry;
wherein
the duty cycle is a ratio of T 3 to T 4 , and
each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes.
17. The implantable stimulator of claim 16 , wherein the primary battery located within the housing has a capacity of less than 60 milliamp-hours (mAh).
18. The implantable stimulator of claim 16 , wherein the internal impedance is greater than 5 ohms.
19. The implantable stimulator of claim 16 , wherein the applying of the stimulation sessions to the patient is configured to treat at least one of obesity, dyslipidemia, and a genitourinary disease of the patient.
20. The implantable stimulator of claim 16 , wherein:
the electrode array comprises a central electrode of a first polarity centrally located on a first surface of a housing of the implantable stimulator and an annular electrode of a second polarity and that is spaced apart from the central electrode; and
the pulse generation circuitry is configured to apply the stimulation sessions to the patient by way of the electrode array by applying the stimulation sessions to the patient by way of the central electrode and the annular electrode.